
Latest News in Parkinson Disease: Predicting Dementia Onset, Prevalence of Dykinesia and OFF Time, and More
An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.
Progression to PD-Related Dementia Predicted by Polygenic Hazard Score
A polygenic hazard score for predicting progression of PD over time to dementia (PDD) was shown in a study published in
- RIMS2 (HR, 4.77; P = 2.78 × 10−11)
- MEM108 (HR, 2.86; P = 2.09 × 10−8)
- WWOX (HR, 2.12; P = 2.37 × 10−8)
- GBA (HR, 1.93; P = .0002)
- APOE (HR, 1.48; P = .001)
As reported by
Findings From AAN 2021 Identify Gaps in Access to Device-Aided Therapies for PD
Discussing findings of an abstract presented at the American Academy of Neurology’s (AAN) 73rd Annual Meeting held virtually April 17-22, 2021, lead author Hubert Fernandez, MD, director of the Center for Neurological Restoration at Cleveland Clinic, spoke in an interview with
His abstract, “Identifying Gaps in Parkinson Disease Patients Eligible for Device-Aided Therapies,” assessed the eligibility for DATs among those with PD via a validated screening tool called MANAGE-PD.
Grouping patients based on their level of DAT eligibility according to oral therapy efficacy, 19% were inadequately controlled by oral therapy and therefore qualified for DAT, although only half were found to have had discussions with providers on future use of these therapies.
Fernandez spoke further during the interview on the immediacy of this therapeutic approach for patients with PD who are eligible and how accurate screening could prove critical for long-term care.
Patient Survey Finds Dyskinesia, OFF Time as Most Prevalent Symptoms in PD
Another study presented at the AAN 73rd Annual Meeting sought to explore the impact of 2 common symptoms in patients with PD,
Analyzing data from 775 surveys, which included 527 patients with PD (68%) and 248 care partners (32%), 78% of respondents reported no or moderate understanding of dyskinesia and OFF, according to
In examining the prevalence of symptom burden, 86% reported daily issues related to dyskinesia and 90% reported daily OFF issues, with more than half of both patient groups reporting having to change plans or activities due to their symptoms (dyskinesia, 61%; OFF, 60%).
Notably, 32% of those affected by dyskinesia said their symptoms have made social interactions more difficult, whereas 27% of those experiencing OFF symptoms were reported to have feelings of isolation and loneliness.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.